Skip to Main Content

Amended review and other takeaways from the latest WCMSA reference guide

On July 31st 2017, the Centers for Medicare and Medicaid Services (CMS) released its most recent version of the Workers’ Compensation Medicare Set-Aside Reference Guide—and there’s a lot to digest. We received some clarification about how CMS will implement the new “Amended Review” option we wrote about previously. CMS also provided “clarifications” and changes for hearings on the merits and state-specific statutes, spinal cord stimulator pricing, and a host of other topics. While a more comprehensive analysis will shortly follow this post, here’s what we know now.

No Second Chance at Amended Review

When CMS expanded the re-review options to include an Amended Review, it allowed parties to request review of all current medical documentation and evidence—even if it postdates the date of the original submission. From the recent release, we learned that (1) settled claims are ineligible for Amended Review requests, (2) the CMS recommendation sheet must be included in the request, and (3) CMS will not develop for missing information. So, to qualify for Amended Review, a file must show that the case:

Leslie Reagan Bodin 537905 Unsplash (1)

  1. has not yet settled as of the date of the request for re-review
  2. was originally submitted to CMS between one and four years from the current date
  3. has no prior request for an Amended Review, and
  4. involves treatment with a reduction or increase of at least 10% or $10,000 (whichever is greater) from the previous CMS-approved WCMSA amount

What We Still Don’t Know about Amended Review

Unfortunately, CMS failed to clarify how reviewers are treating the 10% or $10,000 threshold, so parties should still err on the side of using the higher amount rather than relying on the example in the Workers’ Compensation Medicare Set-Aside Portal (WCMSAP) manual.

More Changes in Version 2.6 of the WCMSA Reference Guide

Please stay tuned as we further dissect these announced changes:

  • Further clarifying expectations of hearings on the merits (Section 4.1.4)
  • Updating defined requirements for spinal cord stimulator pricing (Section 9.4.5)
  • Correcting BCRC contact numbers from previous versions
  • Expanding state-specific statute guidelines (Section 9.4.5)
  • Clarifying total settlement calculations guidelines (Section 10.5.3)
  • Adding ICD-10 examples to sample cover letter
  • Clarifying jurisdictional verification (Section 9.4.4, Step 5)
  • Clarifying change of submitter requirements (Sections 9.0, 10.2, and 19.4)
  • Updating re-review policy (Section 16.0)
  • Adding required resubmission requirements (Section 16.1)
  • Updating administration recommendations (Section 17.1)
  • Adding link (Section 17.6)
  • Updating off-label medication requirements (Section

We’ll soon analyze all the impacts of the new reference guide’s requirements for submitting WCMSAs to CMS for review and approval. Meanwhile, for answers to questions about the recent updates to the WMCSA reference guide, please reach out to Sidney Wong at

Kate Riordan, J.D.

Kate Riordan, J.D., is director of Medicare Secondary Payer initiatives for Casualty Solutions at Verisk. You can contact Kate at

Sid Wong, J.D.

Sid Wong is vice president of policy, Casualty Solutions at Verisk. You can contact Sid at

Visualize Subscribe

Get the best of Visualize!

Get the latest news and insights straight to your inbox.

Subscribe now

You will soon be redirected to the 3E website. If the page has not redirected, please visit the 3E site here. Please visit our newsroom to learn more about this agreement: Verisk Announces Sale of 3E Business to New Mountain Capital.